Ginkgo Bioworks Correlations
| DNA Stock | USD 1.11 0.00 0.00% |
The correlation of Ginkgo Bioworks is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ginkgo Bioworks moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ginkgo Bioworks Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Very weak diversification
The correlation between Ginkgo Bioworks Holdings and NYA is 0.48 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Ginkgo Bioworks Holdings and NYA in the same portfolio, assuming nothing else is changed.
Ginkgo |
The ability to find closely correlated positions to Ginkgo Bioworks could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ginkgo Bioworks when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ginkgo Bioworks - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ginkgo Bioworks Holdings to buy it.
Moving together with Ginkgo Stock
| 0.73 | DVAX | Dynavax Technologies Financial Report 7th of May 2024 | PairCorr |
| 0.63 | VTRS | Viatris Earnings Call This Week | PairCorr |
| 0.68 | EGRX | Eagle Pharmaceuticals | PairCorr |
| 0.73 | ELAN | Elanco Animal Health Financial Report 14th of May 2024 | PairCorr |
| 0.82 | ETON | Eton Pharmaceuticals Upward Rally | PairCorr |
| 0.81 | EVOK | Evoke Pharma | PairCorr |
| 0.8 | IPA | Immunoprecise Antibodies Financial Report 8th of July 2024 | PairCorr |
| 0.73 | JNJ | Johnson Johnson Financial Report 18th of July 2024 | PairCorr |
Moving against Ginkgo Stock
| 0.67 | ACB | Aurora Cannabis Sell-off Trend | PairCorr |
| 0.67 | HCM | HUTCHMED DRC | PairCorr |
| 0.65 | CGC | Canopy Growth Corp Financial Report 27th of June 2024 | PairCorr |
| 0.58 | FLGC | Flora Growth Corp Financial Report 20th of May 2024 | PairCorr |
| 0.45 | SHPH | Shuttle Pharmaceuticals | PairCorr |
Related Correlations Analysis
| 0.73 | 0.44 | 0.77 | -0.02 | -0.13 | OCEA | ||
| 0.73 | 0.51 | 0.57 | 0.23 | 0.14 | ENVB | ||
| 0.44 | 0.51 | 0.47 | 0.34 | 0.07 | HEPA | ||
| 0.77 | 0.57 | 0.47 | -0.17 | -0.56 | ELEV | ||
| -0.02 | 0.23 | 0.34 | -0.17 | 0.57 | AVRO | ||
| -0.13 | 0.14 | 0.07 | -0.56 | 0.57 | CWBR | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Ginkgo Stock performing well and Ginkgo Bioworks Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Ginkgo Bioworks' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| OCEA | 12.12 | 3.19 | 0.38 | 1.05 | 7.38 | 28.92 | 208.65 | |||
| ENVB | 6.32 | 0.40 | 0.08 | 0.28 | 5.24 | 15.29 | 86.10 | |||
| HEPA | 5.65 | (0.25) | 0.00 | (0.68) | 0.00 | 11.79 | 66.21 | |||
| ELEV | 4.78 | 0.62 | 0.16 | 0.43 | 3.98 | 13.28 | 38.12 | |||
| AVRO | 1.63 | (0.07) | 0.00 | 0.20 | 0.00 | 3.03 | 19.09 | |||
| CWBR | 4.16 | (1.83) | 0.00 | (1.17) | 0.00 | 6.67 | 60.37 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Ginkgo Bioworks without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Fundamental Analysis Now
Fundamental AnalysisView fundamental data based on most recent published financial statements |
| All Next | Launch Module |
Ginkgo Bioworks Corporate Directors
Ginkgo Bioworks corporate directors refer to members of a Ginkgo Bioworks board of directors. The board of directors generally takes responsibility for the Ginkgo Bioworks' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Ginkgo Bioworks' board members must vote for the resolution. The Ginkgo Bioworks board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Suchet Sunthorawet | Director | Profile | |
| Sirisak Piyathatsikun | Director | Profile | |
| Benedict Reichel | Company Secretary, Executive Director | Profile | |
| Paul Amatavivadhana | Director | Profile |
Already Invested in Ginkgo Bioworks Holdings?
The danger of trading Ginkgo Bioworks Holdings is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Ginkgo Bioworks is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Ginkgo Bioworks. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Ginkgo Bioworks Holdings is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Ginkgo Bioworks Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ginkgo Bioworks' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ginkgo Bioworks Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ginkgo Bioworks Holdings Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ginkgo Bioworks Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Complementary Tools for Ginkgo Stock analysis
When running Ginkgo Bioworks' price analysis, check to measure Ginkgo Bioworks' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ginkgo Bioworks is operating at the current time. Most of Ginkgo Bioworks' value examination focuses on studying past and present price action to predict the probability of Ginkgo Bioworks' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ginkgo Bioworks' price. Additionally, you may evaluate how the addition of Ginkgo Bioworks to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |
Is Ginkgo Bioworks' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ginkgo Bioworks. If investors know Ginkgo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ginkgo Bioworks listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.46) | Revenue Per Share 0.129 | Quarterly Revenue Growth (0.65) | Return On Assets (0.22) | Return On Equity (0.63) |
The market value of Ginkgo Bioworks Holdings is measured differently than its book value, which is the value of Ginkgo that is recorded on the company's balance sheet. Investors also form their own opinion of Ginkgo Bioworks' value that differs from its market value or its book value, called intrinsic value, which is Ginkgo Bioworks' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ginkgo Bioworks' market value can be influenced by many factors that don't directly affect Ginkgo Bioworks' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ginkgo Bioworks' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ginkgo Bioworks is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ginkgo Bioworks' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.